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Abstract 30 
The dissolution of microporous silica nanoparticles (NP) in aqueous environments of different 31 
biologically relevant pH was studied in order to assess their potential as drug delivery vehicles. 32 
Silica NPs, loaded with fluorescein, were prepared using different organosilane precursors 33 
(tetraethoxysilane, ethyl triethoxysilane or a 1:1 molar ratio of both) and NP dissolution was 34 
evaluated in aqueous conditions at pH 4, pH 6 and pH 7.4. These conditions correspond to 35 
the acidity of the intracellular environment (late endosome, early endosome, cytosol 36 
respectively) and gastrointestinal tract (‘fed’ stomach, duodenum and jejunum respectively). 37 
All NPs degraded at pH 6 and pH 7.4, while no dissolution was observed at pH 4. NP dissolution 38 
could be clearly visualised as mesoporous hollows and surface defects using electron 39 
microscopy, and was supported by UV-Vis, fluorimetry and DLS data. The dissolution profiles 40 
of the NPs are particularly suited to the requirements of oral drug delivery, whereby NPs must 41 
resist degradation in the harsh acidic conditions of the stomach (pH 4), but dissolve and 42 
release their cargo in the small intestine (pH 6 - 7.4). Particle cores made solely of ethyl 43 
triethoxysilane exhibited a ‘burst release’ of encapsulated fluorescein at pH 6 and pH 7.4, 44 
whereas NPs synthesised with tetraethoxysilane released fluorescein in a more sustained 45 
fashion. Thus, by varying the organosilane precursor used in NP formation, it is possible to 46 
modify particle dissolution rates and tune the release profile of encapsulated fluorescein. The 47 
flexible synthesis afforded by silica NPs to achieve pH-responsive dissolution therefore makes 48 
this class of nanomaterial an adaptable platform that may be well suited to oral delivery 49 
applications.   50 
 Graphical Abstract 51 
 52 
 53 
 54 
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Introduction 55 
 56 
Nanoparticle (NP)-based delivery systems have come to prominence over the past two 57 
decades as they can be designed to carry poorly soluble drugs or molecules that are 58 
prone to degradation in biological conditions.1-4 NPs can also transport therapeutics 59 
across highly regulated biological boundaries such as the blood brain barrier.5,6 In 60 
particular, silica NPs (SiNPs) are regularly described as excellent candidates for drug 61 
delivery applications because they are regarded as biocompatible7-9 and inert.10 62 
However, it is the adaptable and flexible nature of siloxane chemistry that makes this 63 
class of nanomaterial so widely studied as a drug delivery agent. This is facilitated, in 64 
part, by the large number of commercially available organosiloxane derivatives that 65 
can be used as precursors for SiNP synthesis. The chemistries of these precursors can 66 
vary widely and means that SiNPs can exhibit a range of useful physicochemical 67 
properties (e.g. different porosity, charge, hydrophobicity), which, in turn, allows for 68 
different kinds of therapeutics to be encapsulated and delivered to disease sites. 69 
  Most silica-based drug delivery studies employ mesoporous silica, having pore 70 
sizes of the order 2-50nm, and rely on tunable cargo release via a ‘gatekeeper’ 71 
strategy.8,11-14 Despite their popularity, the requirement to load cargo and incorporate 72 
gatekeepers after NP synthesis introduces additional complexity to particle design. On 73 
the other hand, microporous silica NPs have characteristic pores of less than 2nm15, 74 
that are challenging to characterise accurately with appropriate methods and 75 
expertise compared to mesoporous silica.16 Encapsulatation of different therapeutics 76 
can be achieved during NP synthesis 2,17,18 and the release mechanism is via the natural 77 
degradation of the silica.19 The process of NP degradation is therefore largely governed 78 
by the organosiloxane precursors, and their associated physicochemical properties, 79 
that can be easily imparted during synthesis.  However, microporous silica remains 80 
understudied as a drug delivery candidate and is more frequently reported in 81 
immunoassays20-22 and bioimaging.9,23-25 This is surprising, considering the adaptable 82 
nature of silica and the fact that it, in comparison to its mesoporous counterpart, 83 
avoids the need for gatekeeping to control drug release and the associated 84 
complications related to cargo leeching. We therefore feel microporous silica NPs are 85 
 4 
an interesting nanomaterial to study and have the potential to impact the drug delivery 86 
field. 87 
  We hypothesise the development of a dissolution-based method of controllably 88 
releasing encapsulated cargo from microporous SiNPs by synthesising colloids using 89 
different organosiloxane precursors. SiNPs are formed utilising hydrolysis but this pH-90 
dependent mechanism is reversible and suggests SiNPs may degrade at different rates 91 
in different acidic conditions.  92 
  Intracellular NP-drug delivery typically requires endocytosis of the nanocarrier 93 
to transport a therapeutic across the cell membrane. Trafficking of the NPs from the 94 
extracellular environment (pH 7.4) into early endosomes (pH 6) and then to late 95 
endosomes/lysosomes (pH 4) means environments of different acidity are 96 
experienced. The same can be said for oral drug delivery applications in which 97 
medicines first encounter the harsh environment of the stomach (pH 4 in ‘fed state’) 98 
and are then passed to the duodenum (pH 6) and jejunum (pH 7.4) for adsorption.  99 
Figure 1: Silica NPs were prepared with different core chemistries by employing different NP precursors during 
synthesis: tetraethoxysilane (TEOS) or ethyl triethoxysilane (ETOS). These NPs were called NPTEOS and NPETOS. TEOS and 
ETOS were also added in an equal molar ratio (NP50-50). Covalently binding fluorescein (FITC) in the NP cores also 
provided information about particle degradation and cargo release. 
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  We have synthesised core-shell SiNPs via the reverse microemulsion method 100 
(Figure 1) and investigated their dissolution in aqueous conditions at biologically 101 
relevant pH (pH 4, pH 6, pH 7.4), similarly to other NP dissolution studies.26-29  Different 102 
siloxane precursors were employed during the core formation in order to produce 103 
particles that exhibit varying degrees of hydrophobicity, which in turn may be able to 104 
affect NP dissolution and the ability to host different cargos. A shell composed of 105 
tetraethoxysilane (TEOS) and negatively charged phosphonates was then added to 106 
each set of particles to insure similar surface chemistry.  107 
 The precursors used for core formation were TEOS, ethyl triethoxysilane (ETOS), 108 
bis(triethoxysilyl)benzene and bis(triethoxsilyl)biphenyl. However, the colloids formed 109 
using the aromatic oxysilanes were unstable in aqueous conditions and only particles 110 
formed using TEOS and ETOS were studied to assess dissolution. Degradation and 111 
release of the encapsulated cargo (i.e. fluorescein; FITC) from the SiNPs were 112 
monitored by electron microscopy and fluorimetry (Figure 2), and stability studies 113 
were carried out using dynamic light scattering (DLS). Overall, negligible dissolution 114 
was observed at pH 4 and suggested the NPs may survive the acidic conditions of the 115 
stomach or cellular lysosome, thus minimising cargo release. NP degradation was 116 
accelerated in pH 6 and pH 7.4 and may support the release the encapsulated cargo in 117 
small intestinal pH, at physiological pH or in early endosomes. A study mimicking 118 
progress through the GI tract (i.e. pH 4 to pH6 to pH 7.4) then showed the NPs released 119 
fluorescein in a pH-dependent manner, with NPs formed using more ETOS exhibiting 120 
‘burst’ release profiles and those formed solely using TEOS displaying ‘slow’ release.  121 
Figure 2: NPs were synthesised using tetraethoxysilane (NPTEOS), ethyl triethoxysilane (NPETOS) or equal ratio of both 
(NP50-50), and were degraded in biologically relevant pH . Dissolution of the NPs was assessed by fluorimetry (FITC 
release from the NPs) and electron microscopy (NP morphology and integrity). 
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Methods 122 
NPs synthesis and characterisation: materials, procedures, size and ζ-potential 123 
analysis, TEM studying of NP dissolution are detailed in the Supporting Information 124 
FITC-release assay: The degree of FITC release was evaluated by measuring the amount 125 
of dye present in the supernatant and comparing the values measured with the 126 
fluorescent-based calibration curve for FITC at the corresponding pH. The values 127 
achieved from the independent experiments are reported as average (n = 3) ± SD. A 128 
Tecan Infinite M200 Pro Safire microplate reader was used for  absorbance and 129 
fluorescence emission measurements. Samples were added to Nunc Maxisorb 96 well 130 
plates before being read (490/525 nm, λex/λem). 250 μg of NPTEOS, NP50-50 and NPETOS 131 
were washed once by centrifugation and re-dispersion in water before dispersion in 1 132 
ml of each phosphate buffer (pH 4, 6 or 7.4). For each sample in each buffer, 7 samples 133 
were prepared, one for each timepoint (1, 2, 4, 6, 8, 10, 24hrs) and shaken at 37°C (600 134 
rpm). After each incubation time, samples were centrifuged (14000rpm, 10 min) and 135 
700μL of supernatant were removed and the remainder discarded. The pellet isolated 136 
after centrifugation was washed twice by centrifugation and re-dispersion in water, 137 
then used for TEM analysis.  138 
GI tract-like assay: 200μg of NPTEOS, NP50-50 and NPETOS were washed once by 139 
centrifugation and re-dispersion in water before dispersion in 1 mL of phosphate 140 
buffer at pH 4. The samples were shaken at 37°C (600 rpm). After 2 hours the samples 141 
were centrifuged, 300μL of the supernatant was measured (λex/λem, 490/525 nm, 142 
100μL per well). The remaining NP suspensions were filled with 300μL of fresh buffer 143 
pH 4 and re-incubated. After 2hr the samples were centrifuged and the supernatants 144 
completely removed and used for the fluorescence analysis, while the pellets were re-145 
dispersed in 1 mL of buffer at pH 6 and shaken at 37°C (600 rpm). After 2 hours, the 146 
samples were centrifuged and the supernatants completely removed and used for the 147 
fluorescence analysis, while the pellets were re-dispersed in 1mL of buffer pH 7.4 and 148 
shaken again. The samples were centrifuged every 2 hours, 300μL of the supernatant 149 
were used to fill three wells of a 96-well plate and the fluorescence was measured. The 150 
experiment was stopped after 12hrs.    151 
 152 
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Results and Discussion 153 
Core-shell microporous SiNPs were synthesised via the reverse microemulsion 154 
method30,31 and their dissolution in biologically relevant pH was investigated. Different 155 
organosiloxane precursors were employed during core formation to produce particles 156 
with varying degrees of hydrophobicity and core crosslinking densities. FITC was 157 
modified with aminopropyl trimethoxysilane via thiourea bond formation and enabled 158 
the dye to be covalently incorporated into the silica matrix during core formation 159 
alongside the SiNP precursors (Figure 1).31,32 A shell composed of TEOS and negatively 160 
charged phosphonates was then added to each set of particles to insure similar surface 161 
chemistry.33 From the organosiloxane analogues chosen for this study, 162 
tetraethoxysilane (TEOS), the traditional SiNP precursor, and ethyl triethoxysilane 163 
(ETOS) were the only analogues capable of forming colloids that were stable in 164 
aqueous conditions. These NPs have been named NPTEOS and NPETOS respectively. TEOS 165 
and ETOS were also added to the microemulsion in equal molar ratios, thus yielding a 166 
third batch of NPs: NP50-50.  167 
  Two other siloxanes, bis(triethoxsilyl)benzene and bis(triethoxsilyl)biphenyl, 168 
were also used alongside TEOS as precursors for NP core formation. It was possible to 169 
generate stable NPs in ethanol using both siloxanes but they visually aggregated in less 170 
than one minute when transferred to DI water (Figure S1). Their rapid aggregation was 171 
attributed to the hydrophobic nature of their aromatic moiety and their potential to π-172 
stack in water, and suggests further surface chemical modification (such as by 173 
PEGylation) would be needed to increase solubility in biological conditions. Even NPs 174 
formed using a 95:5 TEOS:bis(triethoxsilyl)benzene visually aggregated in aqueous 175 
medium (Figure S2). 176 
 177 
Table 1: Physiochemical characterisation of the NPTEOS , NP50-50  and NPETOS by DLS and TEM. FITC loading per NP 178 
was also quantified and allowed for percentage of FITC release to be determined in later dissolution experiments 179 
(n=3). 180 
 
DLS TEM Loading 
  Z-Av. Ø (nm) PDI ζ-potential (mV) Ø (nm) FITC per NP 
NPTEOS 132.5 ± 1.3 0.177 ± 0.016 -27.8 ± 0.80 72 ± 8 1256 ± 389 
NP50-50 170.0 ± 2.2 0.147± 0.005 -24.0 ± 0.27 80 ± 13 1578 ± 574 
NPETOS 222.9 ± 6.0 0.275 ± 0.030 -22.3 ± 0.65 50 ± 31 122 ± 27 
 181 
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  The three NPs (NPTEOS, NP50-50 and NPETOS) were characterised by DLS and 182 
transmission electron microscopy (TEM) in order to quantify particle size and surface 183 
charge (Table 1). Using TEM, the NP diameters were measured to be 72±8 nm, 80±13 184 
nm and 50±31 nm for NPTEOS, NP50-50 and NPETOS respectively. However, using DLS, the 185 
size (Z-average) of the NPTEOS, NP50-50 and NPETOS was 132.5±1.3 nm, 170.0±2.2 nm, 186 
222.9±6.0 nm. The NP Z-average size increased with the increasing proportion of ETOS, 187 
which was accompanied by the decrease of the absolute values of overall negative 188 
charge for the three NPs: -27.8±0.80 mV, -24.0±0.27 mV, -22.3±0.65 mV for NPTEOS, 189 
NP50-50 and NPETOS. This inverted correlation suggested that the NPs became less 190 
colloidally stable and experienced some degree of aggregation when more the 191 
hydrophobic ETOS was used during NP synthesis. No dramatic aggregation over a 192 
period of 2 days was observed for the NPTEOS and NP50-50 at pH 4, pH 6 and pH 7.4 193 
buffers, but at pH 4, the NPETOS diameter increased gradually to 1μm (Figure 3). This 194 
effect is not desirable for drug delivery systems as increased NP size reduces the overall 195 
surface area-to-volume ratio, which is detrimental to controlled drug release, 196 
significantly changes the size-dependent properties of the NPs and may affect NP-cell 197 
interactions. However, in the case of in vivo drug delivery this is unlikely to be 198 
problematic since, in the case of oral administration, the residence time of food in the 199 
stomach is typically 4 hours or less. For intracellular delivery, NPs are likely to be firstly 200 
administered intravenously before reaching a tumour site (i.e. at pH 7.4 where they 201 
are stable). NP localisation in organs usually only then takes a matter of hours, during 202 
which time they are endocytosed and eventually trafficked to late endosomes/ 203 
lysosomes (pH 4).  204 
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  The dissolution of SiNPs is well described in the literature and is caused by 205 
hydrolysis of the silica matrix, which is accelerated at higher pH and temperature.21,34 206 
Park et al described the hollowing of SiNPs due to etching under basic conditions.35 207 
The authors suggested that small ‘seed pores’ in the particle matrix merge to form 208 
single voids and eventually results in large hollows. Mahon et al. demonstrated that 209 
SiNPs can degrade during in vitro cellular experimentation and observed NP hollowing 210 
by TEM following particle incubation in cell culture medium at 37°C.34 We have also 211 
recently observed hollowing in a ‘dissolution assay’ designed to exploit SiNP 212 
degradation as a way to improve immunoassay signal-to-noise ratios.21  213 
  To this end, we have incubated NPTEOS, NP50-50 and NPETOS in buffered solutions 214 
at pH 4, pH 6 and pH 7.4 and analysed the NP integrity (i.e. the presence/absence of 215 
cavities/hollows) as an indicator of degradation. Clear changes in NPs morphology 216 
were observed after 6 hours at 37°C (Figure 4), and a complete 24 hour degradation 217 
study by TEM is presented in the Supporting Information (Figure S3, S4, S5).  It is 218 
evident from Figure 4 that no changes in particle morphology were found for NPTEOS, 219 
NP50-50 or NPETOS when incubated at pH4.  Small mesopore-sized hollows only became 220 
visible at pH4 in NPTEOS after 24 hours of incubation (Figure S3, Table S3). This suggests 221 
that the three types of SiNPs would be robust enough to remain intact in the stomach 222 
(‘fed state’) and presumably also in the ‘fasted state’ (approx. pH 1.2)36,37 because 223 
particle hydrolysis would be slower in more acidic conditions. However, the NPs would 224 
not be capable of intracellular dissolution-based cargo release if the colloids were 225 
eventually trafficked to lysosomes.  226 
Figure 3: DLS analysis of NP size (Z-average, n=3) over a 2 day period in the pH 4, pH 6 and pH 7.4 buffers. (a) 
NPTEOS and NP50-50 were stable over time, but NPETOS gradually aggregated into micron-sized particles over 48 
hours.  (b) All NPs remained colloidally stable for 2 days at pH 6. (c) At pH7.4, the three sets of NPs also retained 
their colloidal stability for 2 days.    
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  At pH 6, we noticed that degradation of the colloids had occurred in the NPTEOS 227 
and NP50-50, but was not evident in the NPETOS particles. For the NP50-50 samples, clear 228 
mesopore-scale hollows measuring 13.71±4.93 nm in diameter in the could be seen 229 
after 2 hours and was further evidenced by the micrographs taken from 6 to 24 hours 230 
in which the etching is seen to be further enhanced (Fig S4, Table 3).  NPTEOS did not 231 
exhibit visible degradation at 2 hours at pH 6 but 6.96±3.73 nm hollows were clearly 232 
evident after 6 hours. Such hollowed structures are consistent with those found in 233 
other studies focussed on SiNP degradation.21,34,35 Interestingly NPETOS exhibited no 234 
visual hollowing in the NP core at pH 6, which is presumably a result of the hydrophobic 235 
ethyl groups reducing the presence of water in the silica matrix, thus inhibiting the 236 
hydrolysis of the –O-Si-O– bond. Interestingly, it appeared that NPETOS underwent a 237 
dissolution process that led to gradual disintegration of the exterior particle surface. 238 
The apparent method of NPETOS degradation is therefore different to that of NPTEOS and 239 
NP50-50, and is presumably linked to the hydrophobic/hydrophilic nature of the 240 
respective particle cores. It is possible that the more hydrophilic cores of NPTEOS and 241 
NP50-50 are susceptible to initial etching by hydrolysis and followed the ‘seed pore’ 242 
phenomenon35 to eventually form mesoscopic cavities. On the other hand, the 243 
hydrophobic NPETOS core resisted hydrolysis and dissolution occurred at the particle 244 
exterior that was formed only by using TEOS. 245 
Figure 4: TEM of NPTEOS, NP50-50, and NPETOS incubated over time in pH 4, pH 6 and pH 7.4 solutions. No changes 
in NP morphology were observed in pH 4 over time which suggested silica NPs may be capable of enduring the 
harsh conditions of the stomach. NPs dissolved in pH 6 and pH7.4 due to the increased rate of hydrolysis of the 
silica matrix. Differences were observed in the mode of dissolution of NPTEOS and NP50-50 compared to NPETOS: 
Hollowing of the particle core was present in NPTEOS and NP50-50, whereas NPETOS degradation appeared to begin 
at the particle exterior surface. 
Commented [G1]: I would say CLEAR hollow formation after 2 h…because, I know it is very hard to see, but there are some, not many, little hollow even after 1h. Othervise thelate it from the table as well 
Commented [CM2]: Is this an appropriate term? 
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  A striking difference in NP integrity was found for particles incubated in pH 7.4 246 
buffer. NPTEOS and NP50-50 exhibited more severe etching after 2 hours incubation 247 
compared to pH 6, which is in agreement with the hypothesis that increased basic 248 
conditions lead to more rapid silica hydrolysis and particle dissolution.  Indeed, it is 249 
clear from the TEM images that NPTEOS and NP50-50 exhibited an evolution from a 250 
microporous structure to a hollowed mesoporous one, which can increase the overall 251 
NP surface area and further enhance degradation. This accelerated NP dissolution for 252 
both sets of NPs at pH 7.4 caused NPTEOS and NP50-50 to be largely degraded after 6 253 
hours. TEM showed very few intact particles and features observed were 254 
predominantly NP debris, which agrees with previous SiNP degradation studies.21 255 
Further analysis of the NP hollows was conducted by scanning transmission electron 256 
microscopy (Figure S6). The results show that the hollowed interior the NPs could 257 
eventually etch through to the surface of NPTEOS and NP50-50 as a way of reducing 258 
surface energy,35 and resulted in distinct surface deformations of the NPs.  259 
  The fact that NPTEOS, NP50-50 and NPETOS all degraded at pH7.4 is promising for 260 
oral drug delivery as the jejunum (pH 7.4) exhibits larger villi compared to do 261 
duodenum (pH 6). This means drugs released at this point in the GI tract would be 262 
readily absorbed, thus improving bioavailability before proceeding to enterohepatic 263 
circulation. Considering that the NP matrix almost completely disintegrates under 264 
these conditions, it may avoid any potential nanotoxicity issues and be cleared from 265 
the body. Indeed, silica is used in the food industry as a bulking agent in a number of 266 
food products (E551; silicium dioxide) and has been reported to degrade into 267 
biocompatible silicic acid.38 However, dissolution of the NPs at pH 7.4 poses a challenge 268 
for intracellular delivery as this strategy first involves intravenous NP injection, which 269 
exposes the NPs to a pH 7.4 environment, and suggests some of the encapsulated 270 
cargo would diffuse from the nanomaterial before localisation.  In turn, the total 271 
amount of drug transported across the cell membrane would be reduced.  272 
  Fluorescein isothiocyanate (FITC) was covalently bound inside the core of 273 
NPTEOS, NP50-50 and NPETOS and served as an indicator of NP degradation. The release 274 
profile of FITC into solution can therefore be used to infer the extent of NP dissolution 275 
and can be corroborated with the TEM images. Due to the hydrophobic nature of FITC 276 
(an analogue for poorly soluble drugs), monitoring the dye release also allowed for 277 
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concurrent assessment of the release profile of small molecules from the three sets of 278 
NPs over time. At each time point, the NPs were centrifuged and intact NPs were 279 
concentrated into a pellet, thus allowing the supernatant to be used for analysing free 280 
FITC released from the NPs (Figure 2). The quantity of dye released was then 281 
extrapolated from the calibration curves of known FITC concentrations prepared at the 282 
three different pHs in order to account for FITC’s pH-dependent fluorescence emission 283 
intensity. The results of this FITC release study are presented in Figure 5. 284 
  FITC release from NPTEOS, NP50-50 and NPETOS was minimal at pH 4 over the course 285 
of 24 hours (Figure 5a). The overall concentration of released FITC was less than 5% 286 
after 2 hours in the acidic environment and when considering the images of intact NPs 287 
obtained via TEM (Figure 4), it suggests that the SiNPs employed in this study would 288 
be capable of resisting degradation in the stomach. They may therefore be able to 289 
reliably carry drugs to the intestine, and agrees with other reports focussed on silica 290 
NP integrity in the stomach and the GI tract as a whole.36,37 This was further supported 291 
by the fact that less than 10% of FITC was released from NPTEOS, NP50-50 and NPETOS at 292 
pH 4 after 24 hours. In addition, the low release rate of the dye into solution suggested 293 
SiNPs intracellularly trafficked to late endosomes/lysosomes would not release 294 
encapsulated cargo via NP dissolution and alternative strategies of ensuring drug 295 
delivery would be needed. For example, strategies like changes to NP shape or surface 296 
chemistry may ensure escape from intracellular vesicles into the more dissolution-297 
friendly conditions of the cytosol (pH 7 - 7.4),39-41 thus avoiding potential NP 298 
exocytosis.42 299 
  At pH 6, an increase in dye release was seen over time for the three NP 300 
formulations, although NPTEOS releases FITC at a slower rate than both NP50-50 and 301 
Figure 5: FITC release from the NPs over time when incubated in gastrointestinal pH’s. (a) NPs were incubated in pH 4 
solution and little FITC was detected in the sample supernatant over a 24 hour period. (b) In pH 6 gradual FITC release 
was observed and was attributed to increased hydrolysis rate compared to pH 4. (c) NP degradation was most rapid in pH 
7.4 and release the majority of the FITC cargo into solution over time. 
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NPETOS in the first 8 hours (Figure 5b). This is likely due to the more highly crosslinked 302 
nature of the core formed solely from TEOS, which results in slower dye diffusion out 303 
of NPTEOS. Nonetheless, it is clear that increasing the pH from 4 to 6 led to more rapid 304 
dye release from the NPs and is attributed to the increased rate of hydrolysis at higher 305 
pH causing particle dissolution.  306 
  The fluorescence data of the NPs at pH 7.4 clearly showed that dye release due 307 
to NP degradation allowed for more rapid release of FITC (Figure 5c). This result 308 
correlated well with the electron microscopy results (Figure 2, S3, S4, S5 S6) from which 309 
it is evident that extensive particle dissolution occurred after 6 hours. More than 55% 310 
of FITC was released from NPTEOS, NP50-50 and NPETOS after 6 hours, which, in the case of 311 
oral drug delivery, suggested that small intestine would be the location where the 312 
majority of drugs would become available for absorption. This is clearly positive as this 313 
would lead to more efficacious delivery of the therapeutic. The loss of dye at pH 7.4 314 
may not be beneficial for intracellular delivery as the cargo can be released before 315 
localising at tumour sites and prior to endocytosis. The fluorescence data also agrees 316 
with the findings of Mahon et al. where dye-leaching from SiNPs caused by NP 317 
dissolution can occur at physiological pH in vitro.34 The authors then developed an 318 
alternative SiNP synthetic approach to prevent SiNP dissolution and dye-leaching in in 319 
vitro conditions.  320 
  Considering the favourable fluorescein retention in acidic conditions and 321 
release at higher pH, we decided to investigate whether the microporous SiNPs 322 
synthesised in this study may be suited to oral drug delivery. FITC release was 323 
monitored over time while increasing the pH, in an attempt to mimic the pH conditions 324 
of the whole GI tract and the digestion process (i.e. stomach, pH 4, to duodenum, pH6, 325 
to jejunum, pH 7.4, Figure 6a). The results are summarised in Figure 6b as free data 326 
points.  327 
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 As expected, at pH 4 the NPs released less than 10% of the FITC cargo over a 4-hour 328 
period. However, when the pH increased to 6 a difference in dye release was observed 329 
for NPTEOS, NP50-50 and NPETOS.  NP50-50 release was higher than NPTEOS and NPETOS at pH 330 
6 solution. However, the most dramatic trend was the ‘burst release’ profile of FITC 331 
from NPETOS whilst incubated at pH 6 and pH 7.4. Only 3% of the FITC cargo was 332 
released at pH 4 over 4 hours, but once the NPETOS experienced small intestine-like 333 
conditions, the rate of release rapidly increased and 70% of dye was released into 334 
solution after 8 hours. The overall release of FITC from NPETOS was 80% after 12 hours. 335 
While NP50-50 showed the highest release of FITC at pH 6, no dramatic increase in 336 
release was observed at pH 7.4, with 62% of the loaded FITC was detected in the 337 
supernatant after 12 hours. On the other hand, NPTEOS exhibited slow dye release at pH 338 
6 and pH 7.4 and released less than 40% of its fluorescent cargo after 12 hours.  339 
  To further understand the FITC release from the NPTEOS, NP50-50 and NPETOS 340 
presented in Figure 6b, the Peppas kinetic model was considered as an appropriate 341 
model to assess diffusion-based cargo release from drug delivery systems.43,44 The 342 
model is typically applied to polymeric systems (SI, Equations 1 and 2). The dye release 343 
was simulated for NPTEOS, NP50-50 and NPETOS and the simulated profiles appeared to fit 344 
the experimental observations well. The same rate constants were used for the fitting 345 
of the NP50-50 and NPETOS data which suggests the incorporation of ETOS in the NP core 346 
led to similar dye diffusion pathways for the two types of colloid. However, the higher 347 
retention of FITC by NP50-50 compared to NPETOS suggested that the former presumably 348 
Figure 6: (a) The pathway through the gastrointestinal tract was mimicked over time. Stomach pH (pH 4) refers to that of 
‘fed state’ and the requirement for some therapeutics like nonsteroidal anti-inflammatory drugs to be administered 
concurrently with food ingestion (b) Marginal FITC was released at pH4. Then, a pH-dependent dye release profile was 
observed for the respective NPs. NPTEOS released FITC slowly and in a sustained manner at pH 6 and pH 7.4. NP50-50 and NPETOS 
displayed initial burst release at pH 6 followed by a steady release at pH 7.4. Greater dye retention in the NPs was observed 
when increased TEOS was used for core formation. The free data points were used to manually fit Higuchi-Peppas models. 
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had a more densely formed silica matrix that eventually limited the release of the dye 349 
during the time period studied. Different rate constants were needed to fit the NPTEOS 350 
data and suggested a different overall FITC release mechanism compared to both NP50-351 
50 and NPETOS. This is consistent with the hypothesis where a higher crosslinking density 352 
in a NP core matrix formed from TEOS alone and was reflected by the higher retention 353 
of FITC after 12 hours. The results presented in Figure 6b therefore show that 354 
increasing the amount of ETOS during NP synthesis would lead to increased cargo 355 
release at the pH found in small intestine (i.e. pH 6 and 7.4). This may prove beneficial 356 
if a ‘burst release’ profile is desirable, whereas it would be preferable to employ NPs 357 
formulated solely from TEOS for slower molecular release into the small intestine.   358 
  These findings established that SiNPs exhibit pH-dependent dissolution profiles, 359 
and it is possible to synthesise SiNPs that exhibit different cargo release profiles that 360 
hold potential in oral drug delivery applications. The ease at which these microporous 361 
NPs were synthesised and shown to exhibit different dissolution behaviour suggests 362 
that a number of further studies should be performed with encapsulated molecules of 363 
various physicochemical properties. We have also previously developed 364 
methodologies for extending SiNP storage and long-term stability, 22,45 and implied that 365 
the successful approaches for synthesising microporous SiNP with drug molecules 366 
could potentially be developed into realistic nano-delivery systems. In addition, the 367 
particles presented here may also be applicable to the emerging field of nano-368 
nutraceuticals;1,44,46 a field concerned with tuning molecule release kinetics and 369 
absorption using nano-sized carriers for more effective nutrient delivery systems. The 370 
use of microporous SiNPs therefore offers a number of potential routes for improved 371 
transport, protection and release of therapies in oral drug delivery and indeed the drug 372 
delivery field as a whole. 373 
 374 
Conclusion 375 
Microporous SiNPs with core-shell architecture were synthesised and their dissolution 376 
in biologically relevant pH (pH 4, pH 6, pH 7.4) was assessed. These pH refer to those 377 
found intracellularly and in the gastrointestinal tract. NP cores were formed using 378 
tetraethoxysilane (NPTEOS), ethyl triethoxysilane (NPETOS) or a 1:1 ratio of both 379 
precursors (NP50-50).  These NPs did not degrade in pH 4 conditions but exhibited 380 
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degradation and fluorescein-release at pH 6 and pH 7.4. This was attributed to 381 
accelerated hydrolysis of the silica matrix at higher pH, the formation of mesopore-382 
sized hollows and subsequent NP dissolution. This suggested that dissolution-based 383 
cargo release from the NPs presented here may be more likely to diffuse from of the 384 
NPs at physiological pH (pH 7.4) before being endocytosed and entering intracellular 385 
vesicles (pH 6 – early endosome, pH 4 - late endosome/lysosome). The degradation of 386 
the NPs at pH 7.4 also infers that this class of nanomaterial could be safely cleared and 387 
excreted. On the other hand, the retention of the fluorescein cargo in acidic conditions 388 
meant the NPs could be applicable to oral drug delivery where drugs required 389 
protection in the stomach. In a mimicked gastrointestinal tract study, increasing the 390 
amount of ETOS in the NP core formation led to increased release of FITC in pH 6 and 391 
pH 7.4 solutions. The release profiles of FITC are consistent with the hypothesis that 392 
cargo release from the NPs is controlled in part by the crosslinking density of the silica 393 
core, with ETOS generating a less dense matrix that facilitates greater cargo release at 394 
small intestinal pH (pH 6 and pH 7.4). The data obtained for NPTEOS suggests this class 395 
of SiNP would be more suited to slow drug release in oral drug delivery applications. 396 
Overall, while further studies are needed to elucidate the degradation mechanisms 397 
associated with the colloidal systems presented here, we showed that it was possible 398 
to tune the release of encapsulated from SiNPs by simply changing the precursor used 399 
during NP synthesis. Microporous SiNPs therefore hold potential as a flexible platform 400 
upon which to base oral drug delivery strategies.  401 
 402 
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Additional experimental information 544 
Materials 545 
Cyclohexane (anhydrous, 99.5%), 1-hexanol (anhydrous, 99%), Triton® X-100, 546 
aminopropyl trimethoxysilane [APTMS] (97%), tetraethoxysilane[TEOS] (99.99%), 547 
ethyltriethoxysilane (96%)[ETOS], 4,4′-Bis(triethoxysilyl)biphenyl (95%) [bis(TE)PP], 4,4′-548 
Bis(triethoxysilyl)benzene (96%) [bis(TE)B], ammonium hydroxide solution (28% w/v in 549 
water, ≥99.99%), 3-(trihydroxysilyl)propyl methylphosphonate monosodium salt (42% 550 
w/v in water) [THPMP], fluorescein isothiocyanate isomer I (≥90%)[FITC], sodium 551 
phosphate dibasic (>98.5%), sodium phosphate monobasic (>98%), sodium carbonate 552 
(≥99.5%), sodium bicarbonate (≥99.5%),  were purchased from Sigma Aldrich. Sodium 553 
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carbonate (0.1M) combined with sodium bicarbonate (0.1M) yielded pH10.6 (9:1 v/v 554 
respectively) solutions. Absolute ethanol, transparent Nunc Maxisorb 96 well plates 555 
were purchased from Fisher Scientific. Carbon Films on 400 Mesh Grids Copper were 556 
purchased from Agar Scientific. 557 
Nanoparticle synthesis 558 
Dye precursor formation: In a dried glass vial, FITC (2.5 mg) was dissolved in 1-hexanol 559 
(2mL) with APTMS (5.6 µL). The reaction was stirred for 2 hours under a nitrogen 560 
atmosphere. 561 
All nanoparticles were formed in a microemulsion prepared by combining 562 
cyclohehexane (7.5 mL), 1-hexanol (1.133 mL), Triton® X-100 (1.894 g) and DI water 563 
(0.48 mL) in a 30 mL plastic bottle under constant stirring. For the formation of the 564 
silica core, TEOS and ETOS were added in different ratios with quantity of oxysilane 565 
being equal 0,45 mmol. 566 
 567 
 568 
 569 
 570 
 
TEOS % (µL) ETOS % (µL) 
NPTEOS 
100% (100) 
/ 
NP50-50 50% (50) 50% (48) 
NPETOS / 100% (97) 
 571 
Dye precursor solution (0.162 mL) was then added. After 30 minutes, 40 µL of 572 
ammonium hydroxide was added to trigger polymerisation. The mixture was stirred 573 
for further 24 hours. Nanoparticle shells were synthesised by adding 50 µL of TEOS. 20 574 
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minutes later 40 µL THPMP was added. After 5 minutes, 10 µL of APTMS was then 575 
added, and the mixture was allowed to stir at RT for another 24hrs. The microemulsion 576 
was then broken by adding 30 mL ethanol. Formed SiNPs were purified by 577 
centrifugation (14000 rpm, 10 min) and re-dispersion in ethanol (x3). After purification, 578 
the NPs were stored in ethanol at 4°C.   579 
Quantification of FITC loading 580 
In order to quantify the amount of FITC loaded during the synthetic procedure, 200 μg 581 
of each type of SiNPs were shaken (600 rpm) at 37°C in sodium carbonate/sodium 582 
bicarbonate (1:9) buffer at pH10.6 as previously reported. 21 After 5 hours, the samples 583 
were centrifuged (14000 rpm, 10 min) and no pellet was observed, meaning that the 584 
particles had dissolved. Three wells of the 96-well plate were filled with 200 μL of the 585 
supernatant isolated after centrifugation. The signal given by FITC molecules free in 586 
solution was compared to a fluorescence/absorbance-based calibration curve of 587 
known concentrations of FITC at pH10.6. The amount of dye loaded in 200 μg of 588 
particle were calculated. From the values obtained, the number of molecules per NP 589 
was calculated by using the spherical volume of the silica NPs calculated from average 590 
TEM diameters. The signal was read at 490/525 nm (λex/λem). Values are reported as 591 
average of three independent batches of particles (n=3) ± SD. 592 
 593 
 594 
Synthesis of NPs using benzene-oxysilanes 595 
The same microemulsion and FITC-loading setup as described above was used except 596 
for the choice of oxysilanes. Again, a total of 0.45mmol of oxysilane was used. TEOS 597 
was used for NP formation alongside either bis(triethoxsilyl)benzene [bis(TE)B] or 598 
bis(triethoxsilyl)biphenyl [bis(TE)PP]. 599 
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TEOS:Bis(TE) B 
TEOS  [µL] 
Bis(TE)B [µL] 
95:5 95 
8.92 
90:10 90 
17.85 
85:15 85 26.77 
75:25 75 44.62 
50:50 50 89.24 
   
TEOS:Bis(TE) PP TEOS  [µL] 
Bis(TE)PP [µL] 
75:25 75 51.44 
50:50 50 102.88 
 600 
Nanoparticle shells were synthesised by adding 50 µL of TEOS, followed by 40 µL of 601 
THPMP and 10 µL of APTMS after 20min and 5min between each other.  After 24h, the 602 
microemulsion was broken by adding 30 mL ethanol. Formed SiNPs were purified by 603 
centrifugation (14000 rpm, 10 min) and re-dispersion in ethanol (3x). After purification, 604 
the nanoparticles were stored in ethanol at 4°C.   605 
Buffer preparation  606 
Phosphate buffer at different pH were prepared mixing 0.2 M sodium phosphate 607 
dibasic and 0.2 M sodium phosphate monobasic and adjusting the pH to 4, 6 and 7.4 608 
using 5 M NaOH and 5 M of HCl.  609 
 610 
NP characterization 611 
 25 
Dynamic light scattering and zetametry: SiNPs were dispersed at a concentration of 612 
500µg/mL in DI water. Their size and zeta-potential were analysed in a disposable 613 
folded capillary cell (DTS1070) at RT using Malvern Zetasizer. n = 3, average ± SD.  614 
SiNP stability:  250µg/mL of NPTEOS, NP50-50 and NPETOS were isolated and re-dispersed 615 
in 1mL of each buffer (pH 4, 6 and 7.4) and incubated at 37°C. Size and zeta potential 616 
were measured by DLS at 0hr, 24hr, 48hr using Malvern Zetasizer. n = 3, average ± SD.  617 
Transmission electron microscopy: NP size quantification following synthesis: 5µL of 618 
NPs in water (500µg/mL) was added on ‘Carbon Films on 400 Mesh Grids Copper’ 619 
(Agar Scientific) and allowed to evaporate. Using ImageJ software, at least 100 NPs 620 
per image were analysed for NP diameter. 621 
SiNPs dissolution using TEM: Following incubation in pH 4, 6, or 7.4 over different 622 
times, NP pellets were isolated using centrifugation (x3), washed using DI water in 623 
order to remove residues salts. The pellet was finally re-dispersed in 200μL DI water, 624 
3µL added to ‘Carbon Films on 400 Mesh Grids Copper’ (Agar Scientific) and allowed 625 
to evaporate. Images were taken on a Joel JEM-3200FS at ×250, ×200, ×150 and ×100 626 
magnification. 627 
 628 
Scanning Transmission Electron Microscopy (STEM): SiNPs dissolution: The same grids 629 
as ‘SiNPs dissolution using TEM’ prepared for TEM analysis for the main text were used 630 
for STEM. The grids were analysed in STEM imaging mode using a Hitachi SU-6600 631 
microscope. Images were taken in secondary electron (SE) and transmission electron 632 
(TE) mode at 130,000 magnification using either 20kV or 25kV accelerating voltage. 633 
The working distance was 8mm. 634 
 635 
Data fitting of with Peppas model for data points in Figure 6b 636 
The data from the release profile of the ‘GI tract-like assay’ was manually simulated 637 
with SigmaPlot using the diffusive models presented by Siepmann and Peppas. 43 638 
Equation 1 was used to fit data from 0 to 4 hours. 639 
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𝑀𝑀𝑡𝑡
𝑀𝑀∞
= (𝑘𝑘𝑠𝑠1)�√𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡� + (𝑘𝑘𝑠𝑠2)(𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡)      640 
 [Eq. 1] 641 
where Mt is the diffused mass at a given time, M∞ is the asymptotic diffused mass at 642 
infinite time, ks1 and ks2 are diffusive and relaxation constants. Equation 2 was used to 643 
fit the data from 4 to 12 hours. 644 
𝑀𝑀𝑡𝑡
𝑀𝑀∞
−
𝑀𝑀4
𝑀𝑀∞
= (𝑘𝑘𝑡𝑡1)�√𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 − 4� + (𝑘𝑘𝑡𝑡2)(𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 − 4)    645 
 [Eq. 2] 646 
where M4 is the predicted diffused mass at the time of changing from pH4 to pH6 (i.e. 647 
after 4 hours). The rate constants used to for Equation 1 and 2 are presented below. 648 
M∞ for NPTEOS, NP50-50 and NPETOS were 45, 63 and 80 respectively. 649 
 
NPTEOS NP50-50 NPETOS 
ks1 0.02 
0.0025 
0.0025 
ks2 0.01 0.005 0.005 
ki1 0.01 0.001 0.001 
ki2 0.05 0.2 0.2 
 650 
 651 
 652 
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Supporting Figures 653 
 654 
 655 
 656 657 
Figure S1: FITC-doped silica NPs were formed by combining the traditional precursor TEOS and either 
bis(triethoxsilyl)benzene, Bis(TE)B, or bis(triethoxsilyl)biphenyl, Bis(TE)PP. The ratio TEOS:Bis(TE)B and 
TEOS:Bis(TE)PP was 75:25 and 50:50. The resultant colloids were soluble in ethanol and dynamic light 
scattering was used to quantify the diameter and zeta potential of the NPs (n=3), as shown in the above table. 
However, when they were dispersed in DI water the NPs visually aggregated in less than 1 minute. [a , b: 
TEOS:Bis(TE)B 75:25, 50:50]; c, d: TEOS:Bis(TE)PP] 
 
Figure S2: Bis(TE)B was incorporated in to FITC-loaded silica NPs in lower molar concentrations as a way 
make the resultant NPs ‘less hydrophobic’ and therefore stable in aqueous conditions. TEOS:Bis(TE)B was 
added to the microemulsion in 95:5, 90:10, 85:15 and were colloidally stable in DI water for 24 hours. However 
when the NPs were dispersed in PBS they visually aggregated after only 10 minutes. 
 28 
Figure S3: The three sets of NPs appeared in tact when incubated over time in pH 4 
 
 29 
 
Figure S4: Degradation was visible by TEM for the three sets of NPs in pH 6 solution over time. Hollowing in the interior of NPTEOS and NP50-50 was observed after 6 – 8 hours 
whereas NPETOS appeared to degrade at the particle surface.   
 
 30 
 
 
 
 
Figure S5: Degradation was visible by TEM for the three sets of NPs in pH 7.4 solution over time. More rapid hollowing of the interior of NPTEOS and NP50-50 was observed compared 
to those observed at pH 6. After 6 – 8 hours few NPs could be isolated after centrifugation and those after that time. NPETOS appeared to degrade at the particle surface. After 10 
hours virtually no NPs were visible by TEM, and structures resembling colloids were highly degraded and surrounded by dissolution debris.   
 31 
Table S3: The size of the NP hollows (or pores) where measured by TEM analysis using the micrographs from Figures S3, S4 and S5.. NM (not measurable) indicates that the particles did 
not present any visible pores, while DISS (dissolved) indicates that no particles were identifiable on the TEM grid and were therefore considered to be dissolved. Values are shown as 
average ± SD (n=30 approximately). 
  0h 1h 2h 4h 6h 8h 10h 24h 
pH4 
NPTEOS NM NM NM NM 9.65±5.30 7.79±3.33 14.11±4.85 32.84±7.69 
NP50-50 NM NM NM NM NM 14.98±6,79 12.77±5.65 11.41±4.25 
NPETEOS NM NM NM NM NM NM NM NM 
pH6 
NPTEOS NM NM NM NM 6.96±3.73 8.07±2.63 11.46±3.37 34.01±8.66 
NP50-50 NM 7.52±2.19 13.71±4.93 11.11±3.18 16.39±5.50 24.61±6.16 20.31±7.32 26.91±6.17 
NPETEOS NM NM NM NM NM NM NM NM 
pH7.4 
NPTEOS NM NM 11.76±3.43 13.45±4.93 4.80±1.44 DISS. DISS. DISS. 
NP50-50 NM 15.39±5.38 14.91±4.80 20.45±6.50 21.16±7.2 13.35±4.40 DISS. DISS. 
NPETEOS NM NM NM NM NM NM DISS. DISS. 
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Figure S6: Scanning transmission electron microscopy allowed for secondary electrons (SE) to be obtained for scanning 
mode while transmission electrons (TE) could be detected simultaneously in transmission mode. (a,b) Scanning electron 
micrographs showed that the surface deformations, highlighted by yellow arrows, were visualised as hollows in 
transmission electron micrographs (c,d). It is therefore suggested to that studies investigating silica NP hollowing/etching 
of the core should also use scanning electron microscopy to interrogate the particle surface, thus providing a more 
accurate evaluation of the overall particle morphology and integrity. 
